Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03344354 · ClinicalTrials.gov registry record · NA
Durability of Double-gloving With Biogel® Surgical Gloves When Used by Clinicians/Surgeons
A NA study, sponsored by Molnlycke Health Care AB.
- Completed
- Registry status
- NA
- Development phase
- 3,507
- Enrollment target
NCT03344354 is a NA study that has completed, run by Molnlycke Health Care AB. The registered enrollment target is 3,507 participants.
The verdict
NCT03344354, a NA study, has completed, sponsored by Molnlycke Health Care AB.
- COMPLETED
- Registry status
- NA
- Development phase
- 3,507 participants
- Enrollment target
Study Summary
A prospective open-label study design was chosen because it will provide the most accurate data on the efficacy of four commercially available similar brands of NRL (natural rubber latex) and synthetic latex surgical gloves when they are used for surgeries in a clinical setting. The primary endpoint will be the overall failure rate of the Biogel® sterile surgical undergloves (device) compared to three undergloves brands of surgical gloves. The secondary endpoints are perforation rates of the underglove, the failure rate of the overglove, the frequency of overglove perforation detection by the glove wearer when double-gloving, the ratio of perforations detected of overglove compared to underglove and to determine the frequency of overglove perforation detection by the glove wearer. The clinical investigation will be statistically powered to test the hypothesis that the failure rate of the Biogel® Sterile Surgical undergloves is different from that of the three comparators.
Interventions
- DEVICE Biogel
- DEVICE Ansell
- DEVICE Cardinal
- DEVICE Medline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,507 participants |
| Start Date | 2018-04-10 |
| Est. Completion | 2022-10-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03344354
The ClinicalTrials.gov registry entry for NCT03344354 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3,507 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Molnlycke Health Care AB, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Biogel is the first listed.
NCT03344354 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03344354 about?
NCT03344354 is a clinical study titled "Durability of Double-gloving With Biogel® Surgical Gloves When Used by Clinicians/Surgeons". A prospective open-label study design was chosen because it will provide the most accurate data on the efficacy of four commercially available similar brands of NRL (natural rubber latex) and synthetic latex surgical gloves when they are used for surgeries in a clinical setting. The primary endpoint...
What is the current status of trial NCT03344354?
This trial is currently completed. It is a NA study. The enrollment target is 3,507 participants. The study started on 2018-04-10. Estimated completion is 2022-10-26.
What interventions are being tested in trial NCT03344354?
The interventions under investigation include: Biogel (DEVICE), Ansell (DEVICE), Cardinal (DEVICE), Medline (DEVICE).
Who is sponsoring clinical trial NCT03344354?
This trial is sponsored by Molnlycke Health Care AB, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.